Chromosomal aberrations in Bilharzial bladder cancer as detected by fluorescence in situ hybridization

被引:9
作者
Aly, MS
Khaled, HM
机构
[1] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo, Egypt
[2] Cairo Univ, Natl Canc Inst, Fac Sci, Cairo, Egypt
关键词
D O I
10.1016/S0165-4608(99)00040-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer of the bladder is a frequent malignancy in Egypt and other developing countries in which bladder infection with the parasite Schistosoma haematobium is common. Several epidemiological, histopathological, and clinical characteristics of cancer of the Bilharzial bladder suggest that it is distinct from bladder cancer seen in other places in the world. No numerical aberrations of chromosomes that might be specific for Bilharzial bladder carcinoma have been established. In this study we used fluorescence in situ hybridization (FISH) with centromere-specific probes for chromosomes 3, 4, 7, 8, 9, 10, 11, 16, and 3 7 to detect numerical aberrations of these chromosomes in frozen-stored samples of 31 Egyptian patients affected with Bilharzial carcinoma. Among 5 types of chromosomes examined, imbalance it as observed; the most common imbalance was a loss of chromosome 9 (48.4%), with numerical aberration of chromosome 17 being the second most-frequent anomaly (19.4%). The presence of such anomalies, especially losses of chromosome 9, are associated with a younger age group of patients, as well as with a lower grade tumor and negative pelvic node involvement by the disease. Fluorescence in situ hybridization analysis thus proved to be a useful method for detecting numerical aberrations of individual chromosomes, with application to touch preparations of frozen-stored tissue having the advantage of exact sampling of cancer foci. This result also suggests that the mechanism of genetic progression of bladder cancer is independent of its etiology. (C) Elsevier Science Inc., 1999. All rights reserved.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 26 条
[1]   INTERPHASE CYTOGENETICS OF PROSTATIC ADENOCARCINOMA AND PRECURSOR LESIONS - ANALYSIS OF 25 RADICAL PROSTATECTOMIES AND 17 ADJACENT PROSTATIC INTRAEPITHELIAL NEOPLASIAS [J].
ALERS, JC ;
KRIJTENBURG, PJ ;
VISSERS, KJ ;
BOSMAN, FT ;
VANDERKWAST, TH ;
VANDEKKEN, H .
GENES CHROMOSOMES & CANCER, 1995, 12 (04) :241-250
[2]   RATES OF P16(MTS1) MUTATIONS IN PRIMARY TUMORS WITH 9P LOSS [J].
CAIRNS, P ;
MAO, L ;
MERLO, A ;
LEE, DJ ;
SCHWAB, D ;
EBY, Y ;
TOKINO, K ;
VANDERRIET, P ;
BLAUGRUND, JE ;
SIDRANSKY, D .
SCIENCE, 1994, 265 (5170) :415-416
[3]  
CAIRNS P, 1993, ONCOGENE, V8, P1083
[4]   P53 MUTATIONS IN HUMAN BLADDER-CANCER - GENOTYPIC VERSUS PHENOTYPIC PATTERNS [J].
CORDONCARDO, C ;
DALBAGNI, G ;
SAEZ, GT ;
OLIVA, MR ;
ZHANG, ZF ;
ROSAI, J ;
REUTER, VE ;
PELLICER, A .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (03) :347-353
[5]   RAPID INTERPHASE AND METAPHASE ASSESSMENT OF SPECIFIC CHROMOSOMAL CHANGES IN NEUROECTODERMAL TUMOR-CELLS BY INSITU HYBRIDIZATION WITH CHEMICALLY MODIFIED DNA PROBES [J].
CREMER, T ;
TESIN, D ;
HOPMAN, AHN ;
MANUELIDIS, L .
EXPERIMENTAL CELL RESEARCH, 1988, 176 (02) :199-220
[6]   GENETIC ALTERATIONS IN BLADDER-CANCER [J].
DALBAGNI, G ;
PRESTI, J ;
REUTER, V ;
FAIR, WR ;
CORDONCARDO, C .
LANCET, 1993, 342 (8869) :469-471
[7]  
ELBOLKAINY MN, 1981, CANCER, V48, P2643, DOI 10.1002/1097-0142(19811215)48:12&lt
[8]  
2643::AID-CNCR2820481216&gt
[9]  
3.0.CO
[10]  
2-C